LEUKEMIA, MYELOMONOCYTIC, CHRONIC
Clinical trials for LEUKEMIA, MYELOMONOCYTIC, CHRONIC explained in plain language.
Never miss a new study
Get alerted when new LEUKEMIA, MYELOMONOCYTIC, CHRONIC trials appear
Sign up with your email to follow new studies for LEUKEMIA, MYELOMONOCYTIC, CHRONIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo aims to delay progression in High-Risk blood cancers
Disease control CompletedThis study tested whether adding pevonedistat to standard azacitidine helps people with certain blood cancers (MDS, CMML, or low-blast AML) live longer without their disease getting worse. About 450 adults at high risk of progression took part. The goal was to see if the combinat…
Matched conditions: LEUKEMIA, MYELOMONOCYTIC, CHRONIC
Phase: PHASE3 • Sponsor: Takeda • Aim: Disease control
Last updated May 26, 2026 08:35 UTC
-
Drug dasatinib shows promise for rare blood cancers
Disease control CompletedThis study tested the drug dasatinib in 68 adults with several blood and bone marrow disorders, including certain leukemias, myelofibrosis, and mastocytosis. The goal was to see if dasatinib could help control these diseases and to check its safety. Results focused on how many pa…
Matched conditions: LEUKEMIA, MYELOMONOCYTIC, CHRONIC
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 18, 2026 11:59 UTC